Navigation Links
A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
Date:1/22/2014

1. Singapore's Agency for Science, Technology and Research (A*STAR) has entered into a research agreement with Nestl today to help boost the company's expansion in R&D in the country. This agreement signed by the two organisations will set the stage for cutting-edge research in areas including packaged food and beverages, food ingredients, nutrition, food manufacturing processes, food science and technology, as well as biotransformation .

2. The framework research agreement will bring together both partners' capabilities and expertise in a range of advanced technologies and research fields that will help Nestl to optimise its production processes and to provide nutritional foods for Nestl's consumers. A*STAR has been developing research capabilities in food and nutrition as one of its five strategic research priorities in the biomedical sciences. This partnership will thus also boost A*STAR's capabilities as the research collaborator of choice in Asia for the global food and nutrition industry.

3. As Asian consumers become more educated and affluent, many food and nutrition companies like Nestl are responding by developing food, health and wellness products customised for Asian markets. In four years, Singapore's total manufacturing output for the food manufacturing sector increased from S$5.7 billion in 2007 to S$8.4 billion in 2011, while the value-added manufacturing output almost doubled from S$1.2 billion to S$2.1 billion. The number of workers employed in food manufacturing also increased 20 per cent over the same time period.

4. The agreement, which involves the participation of all 18 A*STAR research entities, will provide opportunities for researchers across A*STAR to embark on collaborations with Nestl's affiliates globally. A*STAR recently launched a joint centre with National University of Singapore (NUS) - Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development (SiNMeD) to advance research on nutrition, early development and metabolic disease. This agreement will also allow Nestl access to A*STAR's research facilities and technology.

5. Mr Lim Chuan Poh, Chairman of A*STAR said, "A*STAR is looking forward to this excellent opportunity to broaden and deepen the work that we do with the world's leading food and nutrition company to expand their R&D capabilities in Singapore. This agreement marks a significant milestone in propelling forward A*STAR's research thrust into food and nutrition."

6. Stefan Catsicas, Nestl Chief Technology Officer, Head of Innovation, Technology, Research & Development said, "We are delighted to sign this research agreement with A*STAR. It provides the framework for future collaboration that will help to strengthen our food science and technology capabilities in Singapore and beyond."

7. A*STAR has also previously embarked on research projects with Nestl through the EpiGen consortium , to understand optimal nutrition for mothers during pregnancy and for infants to promote metabolic health throughout life.


'/>"/>

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert  

Related biology news :

1. A*STAR scientists discover novel hormone essential for heart development
2. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
3. A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans
4. A*STAR scientists discover potential drug for deadly brain cancer
5. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
6. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
7. Switzerland signs the ELIXIR consortium agreement and contributes €35 million
8. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
9. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
10. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
11. Light and nanoprobes detect early signs of infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/25/2017)... 2017 The Elements of Enterprise Information Security ... comprised of a comprehensive set of business processes ... digital identities and providing a secured and documented ... significant number of programs opted by enterprises to ... optimizing processes and changing policies. However, there are ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Antonio, TX (PRWEB) , ... February 23, 2017 ... ... Drug Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the ... indicated for adults at home or in healthcare facilities during periods of rest. ...
(Date:2/23/2017)... ... 23, 2017 , ... The Greater Gift Initiative, Inc , (GGI) a ... Research . GGI's mission is to advance global health and highlight the greater good ... honor of each clinical trial volunteer. The vision of GGI is to serve as ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one ... been named Fellows of the Society this year, the Fellows Committee has announced. ... fields of optics, photonics, and imaging as well as their service to the ...
(Date:2/22/2017)... 2017  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Annual Biocom Global Life Science Partnering Conference.  The presentation ... at the Torrey Pines Lodge, in San Diego.  ... Biocom who have chosen our company, amongst numerous others, ... investors, and clinical researchers," said Mr. Chen. "In contrast ...
Breaking Biology Technology: